Facebook
Twitter
LinkedIn
Forward
0385_Sutter Neurosciences Grand Rounds_Neurosarcoidosis Diagnosis and Treatment Updates_Live
Description:
Neurologic complications occur in approximately 5 to 10 percent of patients with sarcoidosis. Neurosarcoidosis is a diagnostic consideration in patients with known sarcoidosis who develop neurologic complaints and in patients presenting de novo with a constellation of findings consistent with the disease. Neurosarcoidosis may be asymptomatic but can be life-threatening and tends to occur in cases with systemic involvement. This lecture will address the proper diagnosis of this condition, interpret treatment plans, and better understand immunosuppression and multimodal symptom management and neurorehabilitation to promote recovery.
Target Audience
Physicians (MD or DO)
Other licensed healthcare team members
Learning Objectives
After completing this course, learners will be able to:
1. Analyze updates in diagnosis of neurosarcoidosis and how to distinguish sarcoidosis from other causes of neuroinflammation
2. Differentiate the various treatments of neurosarcoidosis
3. Discuss the pathophysiology of neurosarcoidosis
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
- Lin, J., Pulst-Korenberg, J., Zamvil, S. S., Graves, J., Newsome, S. D., & Amezcua, L. (2023). Tuberculous Meningitis or Neurosarcoidosis—a Diagnostic Quandary: From the National Multiple Sclerosis Society Case Conference Proceedings. Neurology: Neuroimmunology & Neuroinflammation, 11(1), e200184. https://www.neurology.org/doi/full/10.1212/NXI.0000000000200184
- Rossides, M., Darlington, P., Kullberg, S., & Arkema, E. V. (2023). Sarcoidosis: Epidemiology and clinical insights. Journal of internal medicine, 293(6), 668-680. https://onlinelibrary.wiley.com/doi/full/10.1111/joim.13629
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
Jeffrey Gelfand, faculty for this presentation, receives consultant fees from Arialys and VentyxBio as well as grants from Hoffman LaRoche and Vigil Neuroscience. These relevant ineligible relationships were mitigated via a peer review by Dr. Kenneth Laxer who does not have any ineligible financial relationships in common with Dr. Gelfand.
Kenneth Laxer, a planner of this presentation, receives speaker fees from SK Life Science related to Xcorpi. This ineligible relationship was deemed not relevant to the topic of this presentation.
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
Kenneth Laxer, MD, FAAN, FAES, FANA
Jeffrey Gelfand, Associate Professor of Neurology, UCSF
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this LIVE activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Attendance & Credit Claiming
Text the 6-letter attendance verification code to (916) 866-7913 to claim credit.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.